Gene · 10645
Papers2,799
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 2,799
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| CAMKKβ supports growth and viability of epithelial ovarian cancer in vitro and in vivo. | Sci Rep | 2025 | 40676076 | PubTator, text mining | PubMed |
| CaMKK2 as a therapeutic target to combat metastasis in glioblastoma. | Mol Biol Rep | 2025 | 40637941 | PubTator, text mining | PubMed |
| Molecular Dynamics in the Ventral Tegmental Area during Chronic Pain-Induced Negative Affect. | bioRxiv | 2025 | 40631219 | PubTator, text mining | PubMed |
| Identification of a ferroptosis related genes signature and GDF15 contributing to a new perspective for the diagnosis of CRPC. | Sci Rep | 2025 | 40594867 | PubTator, text mining | PubMed |
| The central signaling pathways related to metabolism-regulating hormones of the gut-brain axis: a review. | J Transl Med | 2025 | 40500780 | PubTator, text mining | PubMed |
| Cholesterol metabolism regulated by CAMKK2-CREB signaling promotes castration-resistant prostate cancer. | Cell Rep | 2025 | 40483692 | PubTator, text mining | PubMed |
| Platycodin D reverses tumor necrosis factor-α-induced endothelial dysfunction by increasing nitric oxide through G protein-coupled estrogen receptor-mediated eNOS activity. | Chem Biol Interact | 2025 | 40447174 | PubTator, text mining | PubMed |
| Anti-Inflammasome Effect of Impressic Acid on Diesel Exhaust Particulate Matter-Induced NLRP1 Inflammasome via the Keap1/p62/Nrf2-Signaling Pathway in Keratinocytes. | Antioxidants (Basel) | 2025 | 40427491 | PubTator, text mining | PubMed |
| Contributions of synaptic energetic dysfunction by microtubule dynamics and microtubule-based mitochondrial transport disorder to morphine tolerance. | Br J Pharmacol | 2025 | 40361281 | PubTator, text mining | PubMed |
| CaMKK as a Potential Target for the Natural Product Insecticide Cytisine against Megoura japonica Matsumura. | J Agric Food Chem | 2025 | 40331368 | PubTator, text mining | PubMed |
| Editor's Note: AMPK Causes Cell Cycle Arrest in LKB1-Deficient Cells via Activation of CAMKK2. | Mol Cancer Res | 2025 | 40313094 | PubTator, text mining | PubMed |
| Silencing GGH induces autophagy by increasing folate stress and production of NADH. | J Mol Cell Biol | 2025 | 40268350 | PubTator, text mining | PubMed |
| Self-Powered Thermoelectric Hydrogels Accelerate Wound Healing. | ACS Nano | 2025 | 40241245 | PubTator, text mining | PubMed |
| adverSCarial: assessing the vulnerability of single-cell RNA-sequencing classifiers to adversarial attacks. | Bioinformatics | 2025 | 40234247 | PubTator, text mining | PubMed |
| Role of Ca2+/calmodulin and PI3K/AKT signaling pathways and active ingredients of BaoTaiYin in treatment of recurrent miscarriage. | Front Mol Biosci | 2025 | 40201242 | PubTator, text mining | PubMed |
| Recombinant high-density lipoprotein targeted delivery of celastrol to promote foam cells lipophagy against early atherosclerosis. | J Nanobiotechnology | 2025 | 40119460 | PubTator, text mining | PubMed |
| 3-Hydroxybutyrate Promotes Myoblast Proliferation and Differentiation through Energy Metabolism and GPR109a-Mediated Ca2+-NFAT Signaling Pathways. | J Proteome Res | 2025 | 40099866 | PubTator, text mining | PubMed |
| Orchestrating Intracellular Calcium Signaling Cascades by Phosphosite-Centric Regulatory Network: A Comprehensive Analysis on Kinases CAMKK1 and CAMKK2. | OMICS | 2025 | 40079160 | PubTator, text mining | PubMed |
| Vicenin-2 Hinders Pro-Inflammatory Response via Targeting the CaMKKβ-AMPK-SIRT1 Axis in Lipopolysaccharide-Stressed THP-1 Cells. | Int J Mol Sci | 2025 | 40076701 | PubTator, text mining | PubMed |
| Disruption of ER-mitochondria contact sites induces autophagy-dependent loss of P-bodies through the Ca2+-CaMKK2-AMPK pathway. | J Cell Sci | 2025 | 40071500 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10645/papers?page=6